Targeting EZH2 Promotes Chemosensitivity of BCL-2 Inhibitor through PIK3IP1-PI3K/AKT Axis in Acute Myeloid Leukemia

被引：0
|
作者：
Yang, Chan [1 ]
Zi, Jie [1 ]
Song, Chunhua [2 ]
Ge, Zheng [1 ]
机构：
[1] Southeast Univ, Inst Hematol Southeast Univ, Sch Med, Zhongda Hosp, Nanjing, Peoples R China
[2] Ohio State Univ, Coll Med, Hershey, PA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-152796
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3345
引用
收藏
页数：4
相关论文
共 50 条
  • [31] EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition
    Chen, Fan
    Liu, Jinpeng
    Song, Xiulong
    DuCote, Tanner J.
    Byrd, Aria L.
    Wang, Chi
    Brainson, Christine F.
    CANCER LETTERS, 2022, 524 : 151 - 160
  • [32] Dual PI3K/BCL-2 family inhibition in colorectal cancers with Apc and Pik3camutations
    Miller, Devon D.
    Babiarz, Christopher P.
    Payne, Susan N.
    Pasch, Cheri A.
    Clipson, Linda
    Matkowskyj, Kristina A.
    Deming, Dustin A.
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Dual PI3K/Akt/mTOR Pathway Inhibitor Potentiate Cytarabine Cytotoxicity For Acute Myeloid Leukemia
    Kim, Eun Kyung
    Kang, Hyoung Jin
    Kim, Hyung Joon
    Lee, Ji Won
    Kim, Hyery
    Park, Kyung Duk
    Shin, Hee Young
    Ahn, Hyo Seop
    BLOOD, 2013, 122 (21)
  • [34] MiR-29a mediates the apoptotic effects of TNF-α on endothelial cells through inhibiting PI3K/AKT/BCL-2 axis
    Cao, Yunchang
    Wen, Hongbo
    Leng, Chaoqun
    Feng, Shaolong
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2024, 38 (01)
  • [35] EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia
    Kosalai, Subazini Thankaswamy
    Morsy, Mohammad Hamdy Abdelrazak
    Papakonstantinou, Nikos
    Mansouri, Larry
    Stavroyianni, Niki
    Kanduri, Chandrasekhar
    Stamatopoulos, Kostas
    Rosenquist, Richard
    Kanduri, Meena
    EPIGENETICS, 2019, 14 (11) : 1125 - 1140
  • [36] YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis
    Zhou, Shuai
    Qu, Kang Lin
    Li, Jin Ang
    Chen, Shi Lei
    Zhang, Yi Gang
    Zhu, Chao
    Jin, Hao
    Wang, Yong
    Pang, Qing
    Liu, Hui Chun
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [37] YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis
    Shuai Zhou
    Kang Lin Qu
    Jin Ang Li
    Shi Lei Chen
    Yi Gang Zhang
    Chao Zhu
    Hao Jin
    Yong Wang
    Qing Pang
    Hui Chun Liu
    Cancer Cell International, 21
  • [38] Downregulation of PIK3IP1 in retinal microglia promotes retinal pathological neovascularization via PI3K-AKT pathway activation
    Chen, Lushu
    Cao, Yuan
    Shen, Yaming
    Li, Huan
    Ye, Rong
    Yao, Jin
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [39] Downregulation of PIK3IP1 in retinal microglia promotes retinal pathological neovascularization via PI3K-AKT pathway activation
    Lushu Chen
    Yuan Cao
    Yaming Shen
    Huan Li
    Rong Ye
    Jin Yao
    Scientific Reports, 13
  • [40] Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a
    Mou, Shaofeng
    Zhou, Zhongxin
    He, Yukai
    Liu, Fuxing
    Gong, Lili
    ONCOLOGY LETTERS, 2017, 14 (04) : 4937 - 4942
12345